Monday's Canadian Stock Highlights

The transcript discusses several financial and market updates. It begins with Cinven receiving its first payment from a Canadian drugmaker, which was delisted from the NASDAQ Biotech index due to market capitalization issues. Bombardier's stock performance improved significantly, attributed to reduced capital spending and increased orders. Lastly, Mitel Networks shifted its focus to cloud-based communications, approved a buyback program, and anticipated a significant write-down in the fourth quarter.

What payment did the company make to the European private equity firm Cinven?

What did the Canadian drugmaker say about its liquidity?

What was the reason for the company being taken off the NASDAQ Biotech index?

What factors contributed to the improved picture for the Canadian aircraft maker Bombardier?

What significant action did Mitel's board approve regarding its mobile business?